| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage
|
Chatelut, E.
|
|
2000
|
36 |
2 |
p. 264-269
6 p.
|
artikel
|
| 2 |
Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?
|
Maisey, N.R.
|
|
2000
|
36 |
2 |
p. 200-206
7 p.
|
artikel
|
| 3 |
Assessment of HER2 status in breast cancer
|
Dowsett, M
|
|
2000
|
36 |
2 |
p. 170-176
7 p.
|
artikel
|
| 4 |
Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus
|
Huang, T.-G.
|
|
2000
|
36 |
2 |
p. 249-256
8 p.
|
artikel
|
| 5 |
Comments on: Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer, Fukushima Y, Oshika Y, Tokunaga T, et al., Eur J Cancer 1999, 35, 935–938. Mutant p53 and high expression of MRP are associated in acute myeloblastic leukaemia
|
Turzanski, J.
|
|
2000
|
36 |
2 |
p. 270-271
2 p.
|
artikel
|
| 6 |
Current controversies in cancer tamoxifen for breast cancer prevention
|
Powles, T.J.
|
|
2000
|
36 |
2 |
p. 146-147
2 p.
|
artikel
|
| 7 |
Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice
|
Yan, Y.
|
|
2000
|
36 |
2 |
p. 221-228
8 p.
|
artikel
|
| 8 |
Erratum
|
|
|
2000
|
36 |
2 |
p. 273-281
9 p.
|
artikel
|
| 9 |
Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human gallbladder lesions
|
Yamamoto, S.
|
|
2000
|
36 |
2 |
p. 257-263
7 p.
|
artikel
|
| 10 |
Familial prostate cancer from the Family-Cancer Database
|
Hemminki, K.
|
|
2000
|
36 |
2 |
p. 229-234
6 p.
|
artikel
|
| 11 |
Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer
|
Jönsson, M.
|
|
2000
|
36 |
2 |
p. 242-248
7 p.
|
artikel
|
| 12 |
Non-Hodgkin's lymphoma presenting with spinal cord compression; a clinicopathological review of 25 cases
|
McDonald, A.C.
|
|
2000
|
36 |
2 |
p. 207-213
7 p.
|
artikel
|
| 13 |
Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)
|
Langer, C.J.
|
|
2000
|
36 |
2 |
p. 183-193
11 p.
|
artikel
|
| 14 |
Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study
|
Lhommé, C.
|
|
2000
|
36 |
2 |
p. 194-199
6 p.
|
artikel
|
| 15 |
Response from T. Tokunaga et al.
|
Tokunaga, T
|
|
2000
|
36 |
2 |
p. 271-272
2 p.
|
artikel
|
| 16 |
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
|
Bratt, O
|
|
2000
|
36 |
2 |
p. 235-241
7 p.
|
artikel
|
| 17 |
Tamoxifen for breast cancer prevention
|
Pritchard, K.I
|
|
2000
|
36 |
2 |
p. 148-150
3 p.
|
artikel
|
| 18 |
Tamoxifen for the prevention of breast cancer
|
Fisher, B
|
|
2000
|
36 |
2 |
p. 142-145
4 p.
|
artikel
|
| 19 |
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
|
O'Byrne, K.J.
|
|
2000
|
36 |
2 |
p. 151-169
19 p.
|
artikel
|
| 20 |
Thyroid cancer in children
|
Landau, D.
|
|
2000
|
36 |
2 |
p. 214-220
7 p.
|
artikel
|
| 21 |
Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer
|
Udom, D.I.
|
|
2000
|
36 |
2 |
p. 177-182
6 p.
|
artikel
|
Tijdschrift beschrijving